Citação norma APA

Bernat Peguera, A., Trigueros Peña, M., Ferrando Díez, A., Ibáñez, C., Bystrup, S., Martínez-Cardús, A., . . . Martínez-Balibrea, E. (2021). Efficacy of CT-P6 (trastuzumab biosimilar) versus reference trastuzumab in combination with pertuzumab in HER2-positive early-stage breast cancer: Preclinical and real-life clinical data.

Citação norma Chicago

Bernat Peguera, Adrià, Macedonia Trigueros Peña, Angelica Ferrando Díez, Cristina Ibáñez, Sara Bystrup, Anna Martínez-Cardús, Mireia Margelí, e Eva Martínez-Balibrea. Efficacy of CT-P6 (trastuzumab Biosimilar) Versus Reference Trastuzumab in Combination With Pertuzumab in HER2-positive Early-stage Breast Cancer: Preclinical and Real-life Clinical Data. 2021.

Citação norma MLA

Bernat Peguera, Adrià, et al. Efficacy of CT-P6 (trastuzumab Biosimilar) Versus Reference Trastuzumab in Combination With Pertuzumab in HER2-positive Early-stage Breast Cancer: Preclinical and Real-life Clinical Data. 2021.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.